Jill Woloszynek
Director, Gene Therapy Program Management at Audentes Therapeutics - San Francisco, California, US
Jill Woloszynek's Colleagues at Audentes Therapeutics
Danielle Delorio
Executive Assistant to the Chairman & CEO; President & COO and EVP, CFO
Jill Woloszynek's Contact Details
(415) 818-1005
San Francisco Bay Area
Audentes Therapeutics
Jill Woloszynek's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.